BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 22390404)

  • 1. Heterogeneity of cytokeratin 7 expression in pagetoid Bowen's disease.
    Misago N; Toda S; Narisawa Y
    J Cutan Pathol; 2012 Jul; 39(7):724-6. PubMed ID: 22390404
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytokeratin 10-negative nested pattern enables sure distinction of clonal seborrheic keratosis from pagetoid Bowen's disease.
    Böer-Auer A; Jones M; Lyasnichaya OV
    J Cutan Pathol; 2012 Feb; 39(2):225-33. PubMed ID: 22236073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p63 constitutes a useful histochemical marker for differentiation of pagetoid Bowen's disease from extramammary Paget's disease.
    Memezawa A; Okuyama R; Tagami H; Aiba S
    Acta Derm Venereol; 2008; 88(6):619-20. PubMed ID: 19002351
    [No Abstract]   [Full Text] [Related]  

  • 4. Diffuse CK7, CAM5.2 and BerEP4 positivity in pagetoid squamous cell carcinoma in situ (pagetoid Bowen's disease) of the perianal region: a mimic of extramammary Paget's disease.
    Sah SP; Kelly PJ; McManus DT; McCluggage WG
    Histopathology; 2013 Feb; 62(3):511-4. PubMed ID: 23020200
    [No Abstract]   [Full Text] [Related]  

  • 5. Intraepidermal squamous carcinoma (Bowen's disease) of the nipple.
    Venkataseshan VS; Budd DC; Un Kim D; Hutter RV
    Hum Pathol; 1994 Dec; 25(12):1371-4. PubMed ID: 8001933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 expression in Bowen's disease and in microinvasive squamous cell carcinoma of the skin.
    Hughes JH; Robinson RA
    Mod Pathol; 1995 Jun; 8(5):526-9. PubMed ID: 7675772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pagetoid squamous cell carcinoma in situ (pagetoid Bowen's disease) of the external genitalia.
    Raju RR; Goldblum JR; Hart WR
    Int J Gynecol Pathol; 2003 Apr; 22(2):127-35. PubMed ID: 12649666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of phosphorylated-ATF2 and STAT3 in cutaneous squamous cell carcinoma, Bowen's disease and basal cell carcinoma.
    Chen SY; Takeuchi S; Moroi Y; Hayashida S; Kido M; Chen SJ; Tomoeda H; Uenotsuchi T; Tu YT; Furue M; Urabe K
    J Dermatol Sci; 2008 Sep; 51(3):210-5. PubMed ID: 18547788
    [No Abstract]   [Full Text] [Related]  

  • 9. Partial spontaneous regression of Bowen's disease.
    Murata Y; Kumano K; Sashikata T
    Arch Dermatol; 1996 Apr; 132(4):429-32. PubMed ID: 8629847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-situ squamous cell carcinoma (Bowen's disease) with divergent adnexal differentiation.
    Slater DN; Parsons MA; Mudhar H
    Histopathology; 2003 Jul; 43(1):100. PubMed ID: 12823722
    [No Abstract]   [Full Text] [Related]  

  • 11. Significance of the expression of phosphorylated-STAT3, -Akt, and -ERK1/2 in several tumors of the epidermis.
    Lin N; Moroi Y; Uchi H; Fukiwake N; Dainichi T; Takeuchi S; Takahara M; Tu Y; Furue M; Urabe K
    J Dermatol Sci; 2007 Oct; 48(1):71-3. PubMed ID: 17686614
    [No Abstract]   [Full Text] [Related]  

  • 12. Strong expression of a longevity-related protein, SIRT1, in Bowen's disease.
    Hida Y; Kubo Y; Murao K; Arase S
    Arch Dermatol Res; 2007 May; 299(2):103-6. PubMed ID: 17180656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of keratin 16 in normal and lesional skin of solitary and multiple Bowen's disease using monoclonal antibody Ks 8.12 staining].
    Sheu HM; Ko SS; Yu HS
    J Formos Med Assoc; 1991 Dec; 90(12):1252-5. PubMed ID: 1724782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P16(INK4A) expression in Bowen's disease and Bowenoid papulosis.
    Auepemkiate S; Thongsuksai P; Boonyaphiphat P
    J Med Assoc Thai; 2006 Sep; 89(9):1460-5. PubMed ID: 17100385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of E-cadherin and beta-catenin in Bowen's disease and squamous cell carcinoma].
    Li ZX; Peng ZH; Ji FP; Yuan JY; Pan M; Liu Y; Wang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1245-7. PubMed ID: 16939929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Merkel cell carcinoma concurrent with Bowen's disease: two cases, one with an unusual immunophenotype.
    Ishida M; Okabe H
    J Cutan Pathol; 2013 Sep; 40(9):839-43. PubMed ID: 23672777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunolabeling pattern of syndecan-1 expression may distinguish pagetoid Bowen's disease, extramammary Paget's disease, and pagetoid malignant melanoma in situ.
    Bayer-Garner IB; Reed JA
    J Cutan Pathol; 2004 Feb; 31(2):169-73. PubMed ID: 14690462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of KLF4 in UVB-induced murine skin tumor development and its correlation with cyclin D1, p53, and p21(Waf1/Cip1) in epithelial tumors of the human skin.
    Choi WJ; Youn SH; Back JH; Park S; Park EJ; Kim KJ; Park HR; Kim AL; Kim KH
    Arch Dermatol Res; 2011 Apr; 303(3):191-200. PubMed ID: 21132436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical localization of keratins and involucrin in solar keratosis and Bowen's disease.
    Ichikawa E; Watanabe S; Otsuka F
    Am J Dermatopathol; 1995 Apr; 17(2):151-7. PubMed ID: 8600780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bowen's disease with invasive adnexal carcinoma: the pluripotential nature of Bowen's disease cells.
    Kamiya H; Kitajima Y; Ban M
    J Dermatol; 2006 Dec; 33(12):858-64. PubMed ID: 17169090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.